Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS2 | P35228 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.37 |
| ▸ | TSHR | P16473 | 3/20 | 0.37 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | DAO | P14920 | 1/20 | 0.34 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.33 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.33 |
| ▸ | CD44 | P16070 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.33 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.33 |
| ▸ | GRM5 | P41594 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL27657593 | 0.98 | NOS2 (0.36) | NOS2CYP3A4TSHRPIK3CAALDH1A1 | |
| Ethylene SCHEMBL27977899 | 0.96 | NOS2 (0.35) | NOS2CYP3A4TSHRPIK3CAALDH1A1 | |
| SCHEMBL27548295 | 0.89 | GABRA1 (0.37) | NOS2CYP3A4TSHRPIK3CAALDH1A1 | |
| SCHEMBL3697918 | 0.86 | CYP3A4 (0.43) | NOS2CYP3A4TSHRPIK3CAALDH1A1 | |
| SCHEMBL23609209 | 0.85 | TAAR1 (0.41) | — | |
| SCHEMBL453688 | 0.85 | CA2 (0.32) | TSHRALDH1A1HPGDKDM4EGAA | |
| SCHEMBL9563230 | 0.84 | ALDH1A1 (0.35) | NOS2CYP3A4TSHRPIK3CAALDH1A1 | |
| SCHEMBL1452942 | 0.84 | ALDH1A1 (0.41) | NOS2TSHRALDH1A1HPGDKDM4E | |
| Diethylaniline SCHEMBL18092108 | 0.83 | TSHR (0.41) | CYP3A4TSHRALDH1A1HPGDKDM4E | |
| SCHEMBL140512 | 0.83 | SKP2 (0.43) | CYP3A4TSHRPIK3CACYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 331 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111018718-B | Preparation method of halogen substituted alkylaniline | 青岛凯源祥化工有限公司 | 2023-02-07 | — | — | CN | claimed |
| CN-111018718-A | Preparation method of halogen substituted alkylaniline | 青岛凯源祥化工有限公司 | 2020-04-17 | — | — | CN | claimed |
| CN-110551054-A | maleimide derivative, and preparation method and application thereof | TECHNICAL INST PHYSICS & CHEMISTRY CAS | 2019-12-10 | — | — | CN | claimed |
| US-9371347-B2 | dppf-like compounds and method of manufacture and use | BROWN UNIVERSITY (US) | 2016-06-21 | — | — | US | claimed |
| US-20160002274-A1 | dppf-LIKE COMPOUNDS AND METHOD FO MANUFACTURE AND USE | NATIONAL SCIENCE FOUNDATION | 2016-01-07 | — | — | US | claimed |
| WO-2014130410-A1 | DPPF-LIKE COMPOUNDS AND METHODS | BROWN UNIVERSITY (US) | 2014-08-28 | — | — | WO | claimed |
| CN-1304486-C | Phthalocyanine compound, process for producing the same, and optical recording medium containing the same | MITSUI CHEMICALS INC (JP) | 2007-03-14 | — | — | CN | claimed |
| US-5504257-A | Process for producing diisopropyl ether with removal of acid material | UOP (US) | 1996-04-02 | — | — | US | claimed |
| US-4857657-A | Preparation of hexenedioic acid diesters | RHONE-POULENC CHIMIE (FR) | 1989-08-15 | — | — | US | claimed |
| EP-4731689-A1 | METHOD FOR THE PRODUCTION OF THERMOPLASTIC POLYOXAZOLIDINONE | Covestro Deutschland AG (DE) | 2026-04-29 | — | — | EP | disclosed |
| US-12543674-B2 | Embryogenesis factors for cellular reprogramming of a plant cell | PIONEER HI-BRED INTERNATIONAL, INC. (US) | 2026-02-10 | — | — | US | disclosed |
| EP-4448605-B1 | PROCESS FOR THE PRODUCTION OF A THERMOPLASTIC POLYOXAZOLIDINONE | COVESTRO DEUTSCHLAND AG (DE) | 2025-11-19 | — | — | EP | disclosed |
| EP-4200353-B1 | METHOD FOR THE PRODUCTION OF A THERMOPLASTIC POLYOXAZOLIDINONE | COVESTRO DEUTSCHLAND AG (DE) | 2025-11-19 | — | — | EP | disclosed |
| EP-4200351-B1 | METHOD FOR THE PRODUCTION OF A THERMOPLASTIC POLYOXAZOLIDINONE | COVESTRO DEUTSCHLAND AG (DE) | 2025-11-19 | — | — | EP | disclosed |
| US-4164511-A | Manufacture of N-arylglycinonitriles | BASF AKTIENGESELLSCHAFT (DE) | 1979-08-14 | — | — | US | disclosed |
| US-4116929-A | POLYESTERS | EASTMAN KODAK COMPANY (US) | 1978-09-26 | — | — | US | disclosed |
| US-4115413-A | ACID FREE | BAYER AKTIENGESELLSCHAFT (DE) | 1978-09-19 | — | — | US | disclosed |
| US-4064126-A | Process for the production of orotic acid | LONZA, LTD. (CH) | 1977-12-20 | — | — | US | disclosed |
| US-4017508-A | POLYMERS | EASTMAN KODAK COMPANY (US) | 1977-04-12 | — | — | US | disclosed |
| US-3968188-A | Process for preparing the pentaerythritol ester of phosphorohalidous acid | MONSANTO COMPANY (US) | 1976-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160002274-A1 | dppf-LIKE COMPOUNDS AND METHOD FO MANUFACTURE AND USE | DBF4, CD22, CD2BP2 | NOS2 1392/4885CYP3A4 437/4885TSHR 2129/4885 |
| US-12543674-B2 | Embryogenesis factors for cellular reprogramming of a plant cell | CCNB2, CCNB1, CCNB3 | NOS2 4232/4885CYP3A4 4593/4885TSHR 3536/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.